Nerve sparing for men with high-risk prostate cancer undergoing RALP
Nerve-sparing in high-risk patients undergoing robot-assisted laparoscopic prostatectomy (RALP) for prostate cancer.
We are investigating the oncological effect of nerve sparing for men with high-risk prostate cancer undergoing RALP. Functional outcomes after non-nerve sparing (non-NS) RALP are poor, and strongly correlated to worse QoL. Therefore, it is important to understand if there are patients with high-risk PC that can undergo NS without increasing the risk for affecting the oncological outcomes. We are using data from a Karolinska database of 780 men who underwent RALP between 2002-2016 for high-risk PCa and evaluate the frequencies of biochemical recurrences and cancer-specific deaths.